new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Seikagaku Corporation
Seikagaku Corporation Central Research Laboratorie
  

Seikagaku Corporation patents

Recent patent applications related to Seikagaku Corporation. Seikagaku Corporation is listed as an Agent/Assignee. Note: Seikagaku Corporation may have other listings under different names/spellings. We're not affiliated with Seikagaku Corporation, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Seikagaku Corporation-related inventors




Date Seikagaku Corporation patents (updated weekly) - BOOKMARK this page
01/05/17Therapeutic agent for disc herniation
01/05/17Diamine crosslinking agents, crosslinked acidic polysaccharides and medical materials
12/29/16Alpha-oxoacyl amino-caprolactam derivative
08/18/16Method for improving blood persistence of protein
07/07/16Drug containing cationized chitosan
06/09/16Pharmaceutical composition for respiratory administration
06/02/16Glycosaminoglycan derivative and producing same
05/19/16Alpha-oxoacyl amino-caprolactam derivative
05/12/16Alpha-oxoacyl amino-caprolactam body
04/28/16Heparosan-glucuronic acid-5-epimerase, and producing polysaccharide using same
03/03/16Pre-treatment agent and pre-treatment antithrombin iii to be subjected to limulus test
10/29/15Novel recombinant factor c and producing the same, and measuring endotoxin
10/08/15Pharmaceutical agent having long-lasting effect of treating arthritic disorders
09/10/15Method for measuring endotoxin
07/16/15Agent for applying to mucosa and the production thereof
04/02/15Pharmaceutical agent having long-lasting effect of treating arthritic disorders
03/12/15Therapeutic agent for disc herniation
01/23/14Agent for measuring endotoxin
11/21/13Nucleic acid fragment encoding a horseshoe crab-derived pro-clotting enzyme
10/10/13Therapeutic agent for disc herniation
08/01/13Novel chondroitin sulfate having decreased molecular weight and use thereof
11/22/12Medical composition for protuberance of epithelium
06/07/12Pharmaceutical composition for relieving pain
03/08/12Polysaccharide pseudo-sponge
12/29/11Method for assaying keratan sulfate, assay kit therefor and detecting joint disease by using the same
11/24/11Promoter for hard tissue formation
10/20/11Method for detecting lysosomal storage diseases
09/15/11Hyaluronic acid oligosaccharide fractions and drugs containing the same
08/25/11Agent for applying to mucosa and the production thereof
08/18/11Nucleus pulposus filler
08/11/11Modified chondroitin synthase polypeptide and crystal thereof
06/23/11Method of detecting articular cartilage degeneration or damage
05/26/11Mutant glycoprotein resistant to modification with asparagine-linked sugar chain
04/28/11Crosslinked polysaccharide sponge
04/14/11Hyaluronic acid derivative and drug containing the same
03/10/11Improving agent for dysfunction due to neuropathy and rho kinase activation inhibitor
03/03/11Pharmaceutical agent having long-lasting effect of treating arthritic disorders
02/10/11Method of measuring lipoarabinomannan and application thereof
01/13/11Radical therapeutic agent for keloid and hypertrophic scar
11/11/10Novel chondroitin sulfate having decreased molecular weight and use thereof
07/01/10Fungal growth inhibitor
06/17/10Chondroitin-producing bacterium and producing chondroitin
05/06/10Method for producing factor g derived from horseshoe crab
03/18/10Modified chondroitin synthase polypeptide and crystal thereof
02/18/10Method for determination of molecular weight of hyaluronic acid
12/31/09Medical composition for protuberance of epithelium
11/26/09Hybridoma capable of producing anti-dectin-1 monoclonal antibody
11/26/09Hyaluronic acid oligosaccharide fractions and drugs containing the same
11/12/09Anti-2-o-desulfated acharan sulfate antibody and its application
11/12/09Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient
11/05/09Anti-acharan sulfate antibody and its application
10/29/09Alpha 1,4-galactosyltransferase and dna encoding thereof
10/29/09In vivo generation of dna, rna, peptide, and protein libraries
10/22/09Long-chain chondroitin sugar chain and producing the same and promoting synthesis of chondroitin
09/17/09Process for producing chondroitin
08/20/09Pro-clotting enzyme, and detection of endotoxin or (1-3)-beta-d-glucan using the same
08/20/09Therapeutic agent for rheumatoid arthritis
06/18/09Novel process for preparation of chondroitin fraction
06/18/09Cycloalkane carboxamide derivatives and production process of same
05/28/09Biologically active peptide and agent containing the same
05/28/09Cycloalkylcarbonylamino acid ester derivative and process for producing the same
05/21/09Oxazolone derivatives
05/07/09Method of eliminating reactivity of lipoarabinomannan and application of the same
04/30/09Cycloalkylcarbonylamino acid derivative and process for producing the same
04/23/09Method for determination of enzymatic activity
Patent Packs
04/23/09Method of producing polysaccharide derivatives
05/28/09Novel anti-heparan sulfate antibody, detection of heparan sulfate, and kit for detection of heparan sulfate







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Seikagaku Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Seikagaku Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';